Tailored Cognitive-Behavioral Therapy for Fibromyalgia Patients at Risk
Tailored Cognitive-Behavioral Therapy for Fibromyalgia Patients at Risk: A Randomized, Controlled Trial
Sponsor: Radboud University Medical Center
A NA clinical study on Fibromyalgia, this trial is completed. The trial is conducted by Radboud University Medical Center and has accumulated 6 data snapshots since 2003. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Mar 2022 — Jul 2024 [monthly]
Completed NA
-
Jan 2021 — Mar 2022 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed NA
First recorded
Dec 2003
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Radboud University Medical Center
- Reumafonds
- Sint Maartenskliniek
- ZonMw: The Netherlands Organisation for Health Research and Development
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • 's-Hertogenbosch, Netherlands
- • Arnhem, Netherlands
- • Nijmegen, Netherlands